| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 148, Issue 2 485-490, Copyright © 1992 by American Association of Immunologists
ARTICLES |
SM Wahl, JB Allen, GR Welch and HL Wong
Cellular Immunology Section, National Institute of Dental Research, National Institutes of Health, Bethesda, MD 20892.
Mononuclear phagocytes in the synovium of patients with arthritis, in contrast to blood monocytes, were found to express a third receptor for the constant region of Ig (Fc gamma RIII), in addition to Fc gamma RI and Fc gamma RII. Previously identified on mature mononuclear phagocytes or phagocytes exposed to transforming growth factor-beta (TGF-beta) in vitro, this study documents the presence of Fc gamma RIII (CD16) expressing cells at an inflammatory site. Furthermore, the presence of CD16 on the majority of the LeuM3 (CD14) positive synovial monocytic cells could be mimicked by exposing blood monocytes to synovial fluids from patients with rheumatoid arthritis (17 of 19) and synovial fluids from patients with osteoarthritis (4 of 4). In additional studies, the soluble factor in inflammatory synovial fluids responsible for regulating CD16 expression was found to be consistent with the presence of TGF-beta. Inhibition of the activity in synovial fluids with a neutralizing antibody to TGF-beta confirmed a role for this peptide in synovial phagocytic cell CD16 expression. Moreover, signal transduction through CD16 on synovial phagocytes resulted in augmented extracellular release of superoxide anion that may contribute to tissue damage and other inflammatory sequelae. Identification of TGF- beta and its association with upregulation of CD16 at sites of chronic inflammation may provide insight into the destructive lesions associated with inflammatory arthropathies.
This article has been cited by other articles:
|
|
 |
|
  L. Ziegler-Heitbrock The CD14+ CD16+ blood monocytes: their role in infection and inflammation J. Leukoc. Biol., March 1, 2007; 81(3): 584 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Webster, K. Kedzierska, R. Azzam, G. Paukovics, J. Wilson, S. M. Crowe, and A. Jaworowski Phagocytosis stimulates mobilization and shedding of intracellular CD16A in human monocytes and macrophages: inhibition by HIV-1 infection J. Leukoc. Biol., February 1, 2006; 79(2): 294 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wijngaarden, J. A. G. van Roon, J. G. J. van de Winkel, J. W. J. Bijlsma, and F. P. J. G. Lafeber Down-regulation of activating Fc{gamma} receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment Rheumatology, June 1, 2005; 44(6): 729 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Hepburn, J. C. Mason, and K. A. Davies Expression of Fc{gamma} and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis Rheumatology, May 1, 2004; 43(5): 547 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wijngaarden, J. A. G. van Roon, J. W. J. Bijlsma, J. G. J. van de Winkel, and F. P. J. G. Lafeber Fc{gamma} receptor expression levels on monocytes are elevated in rheumatoid arthritis patients with high erythrocyte sedimentation rate who do not use anti-rheumatic drugs Rheumatology, May 1, 2003; 42(5): 681 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Shah, D. Foreman, and M. Ferguson Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents J. Cell Sci., January 5, 1994; 107(5): 1137 - 1157. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Del Giudice and M. K. Crow Review: Role of Transforming Growth Factor Beta (TGF{beta}) in Systemic Autoimmunity Lupus, August 1, 1993; 2(4): 213 - 220. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
